These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29973008)

  • 21. Recommendations for rotavirus vaccine.
    Lee PI; Chen PY; Huang YC; Lee CY; Lu CY; Chang MH; Lin YZ; Chiu NC; Ni YH; Chen CM; Chang LY; Tang RB; Huang LM; Huang YF; Hwang KP; Hwang B; Lin TY
    Pediatr Neonatol; 2013 Dec; 54(6):355-9. PubMed ID: 23746943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Preliminary Assessment of Rotavirus Vaccine Effectiveness in Zambia.
    Beres LK; Tate JE; Njobvu L; Chibwe B; Rudd C; Guffey MB; Stringer JS; Parashar UD; Chilengi R
    Clin Infect Dis; 2016 May; 62 Suppl 2():S175-82. PubMed ID: 27059353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of Lanzhou lamb rotavirus vaccine in preventing gastroenteritis among children younger than 5 years of age.
    Li J; Zhang Y; Yang Y; Liang Z; Tian Y; Liu B; Gao Z; Jia L; Chen L; Wang Q
    Vaccine; 2019 Jun; 37(27):3611-3616. PubMed ID: 31122857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Cortese MM; Parashar UD;
    MMWR Recomm Rep; 2009 Feb; 58(RR-2):1-25. PubMed ID: 19194371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementation of rotavirus immunization in Philadelphia, Pennsylvania: high levels of vaccine ineligibility and off-label use.
    Daskalaki I; Spain CV; Long SS; Watson B
    Pediatrics; 2008 Jul; 122(1):e33-8. PubMed ID: 18595974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1999 Mar; 48(RR-2):1-20. PubMed ID: 10219046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants.
    Ruiz-Palacios GM; Guerrero ML; Bautista-Márquez A; Ortega-Gallegos H; Tuz-Dzib F; Reyes-González L; Rosales-Pedraza G; Martínez-López J; Castañón-Acosta E; Cervantes Y; Costa-Clemens S; DeVos B
    Pediatrics; 2007 Aug; 120(2):e253-61. PubMed ID: 17606534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rotavirus shedding following administration of RV3-BB human neonatal rotavirus vaccine.
    Cowley D; Boniface K; Bogdanovic-Sakran N; Kirkwood CD; Bines JE
    Hum Vaccin Immunother; 2017 Aug; 13(8):1908-1915. PubMed ID: 28481726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries.
    Tu HA; Rozenbaum MH; Coyte PC; Li SC; Woerdenbag HJ; Postma MJ
    Vaccine; 2012 Feb; 30(8):1521-8. PubMed ID: 22119590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rotavirus vaccine series completion and adherence to vaccination schedules among infants in managed care in the United States.
    Krishnarajah G; Davis EJ; Fan Y; Standaert BA; Buikema AR
    Vaccine; 2012 May; 30(24):3717-22. PubMed ID: 22214886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Live attenuated tetravalent (G1-G4) bovine-human reassortant rotavirus vaccine (BRV-TV): Randomized, controlled phase III study in Indian infants.
    Saluja T; Palkar S; Misra P; Gupta M; Venugopal P; Sood AK; Dhati RM; Shetty A; Dhaded SM; Agarkhedkar S; Choudhury A; Kumar R; Balasubramanian S; Babji S; Adhikary L; Dupuy M; Chadha SM; Desai F; Kukian D; Patnaik BN; Dhingra MS
    Vaccine; 2017 Jun; 35(28):3575-3581. PubMed ID: 28536027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating the first introduction of rotavirus vaccine in Thailand: Moving from evidence to policy.
    Tharmaphornpilas P; Jiamsiri S; Boonchaiya S; Rochanathimoke O; Thinyounyong W; Tuntiwitayapun S; Guntapong R; Riewpaiboon A; Rasdjarmrearnsook AO; Glass RI
    Vaccine; 2017 Feb; 35(5):796-801. PubMed ID: 28057385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of the live attenuated rotavirus vaccine produced by a domestic manufacturer in China studied using a population-based case-control design.
    Zhen SS; Li Y; Wang SM; Zhang XJ; Hao ZY; Chen Y; Wang D; Zhang YH; Zhang ZY; Ma JC; Zhou P; Zhang Z; Jiang ZW; Zhao YL; Wang XY
    Emerg Microbes Infect; 2015 Oct; 4(10):e64. PubMed ID: 26576341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rotavirus vaccination effectiveness: a case-case study in the EDICS project, Castellón (Spain).
    Bellido-Blasco JB; Sabater-Vidal S; Salvador-Ribera Mdel M; Arnedo-Pena A; Tirado-Balaguer MD; Meseguer-Ferrer N; Silvestre-Silvestre E; Romeu-García MÀ; Herrero-Carot C; Moreno-Muñoz MR
    Vaccine; 2012 Dec; 30(52):7536-40. PubMed ID: 23103196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Jan; 119(1):171-82. PubMed ID: 17200286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity of a three dose and five dose oral human rotavirus vaccine (RIX4414) schedule in south Indian infants.
    Kompithra RZ; Paul A; Manoharan D; Babji S; Sarkar R; Mathew LG; Kang G
    Vaccine; 2014 Aug; 32 Suppl 1():A129-33. PubMed ID: 25091666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants.
    Phua KB; Quak SH; Lee BW; Emmanuel SC; Goh P; Han HH; De Vos B; Bock HL
    J Infect Dis; 2005 Sep; 192 Suppl 1():S6-S16. PubMed ID: 16088807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The composition of demand for newly launched vaccines: results from the pneumococcal and rotavirus vaccine introductions in Ethiopia and Malawi.
    Williams BA; Kidane T; Chirwa G; Tesfaye N; Prescott MR; Scotney ST; Valle M; Abebe S; Tambuli A; Malewezi B; Mohammed T; Kobayashi E; Wootton E; Wong R; Dosani R; Subramaniam H; Joseph J; Yavuz E; Apple A; Le Tallec Y; Kang'ethe A
    Health Policy Plan; 2016 Jun; 31(5):563-72. PubMed ID: 26856361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential epidemiological and economical impact of two rotavirus vaccines in Colombia.
    De la Hoz F; Alvis N; Narváez J; Cediel N; Gamboa O; Velandia M
    Vaccine; 2010 May; 28(22):3856-64. PubMed ID: 20347057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of the human rotavirus vaccine RIX4414 in malnourished children.
    Perez-Schael I; Salinas B; Tomat M; Linhares AC; Guerrero ML; Ruiz-Palacios GM; Bouckenooghe A; Yarzabal JP
    J Infect Dis; 2007 Aug; 196(4):537-40. PubMed ID: 17624838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.